Advanced glycation end-products: a review
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Advanced glycation end-products are a complex and heterogeneous group of compounds that have been implicated in diabetes related complications. At present it is not known if they are the cause or the consequence of the complications observed. We discuss the chemistry of advanced glycated end-product formation and their patho-biochemistry particularly in relation to the diabetic microvascular complications of retinopathy, neuropathy and nephropathy as well as their role in the accelerated vasculopathy observed in diabetes. The concept of carbonyl stress as a cause for advanced glycated end-product toxicity is mentioned. We discuss alterations in the concentrations of advanced glycated end-products in the body, particularly in relation to changes occurring with age, diabetes and its complications such as nephropathy. Problems relating to current methods of advanced glycated end-product detection and measurement are highlighted including the lack of a universally established method of detection or unit of measurement. Agents used for the treatment of advanced glycated end-product accumulation are reviewed, with an emphasis on the results of the recent phase III trials using aminoguanidine and diabetes related complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About 20 various AGEs have been detected in blood and tissues, as well as in foods.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The most abundant non-fluorescence AGEs involve carboxymethyl-lysine (CML), and carboxyethyl-lysine (CEL). Fluorescence AGEs involve methylglyoxal-lysine and pentosidine (Singh et al. 2001).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The Maillard reaction generates these highly reactive dicarbonyls, also referred to as 𝛼-oxoaldehydes, which in addition to methylglyoxal include glyoxal and 3deoxyglucosone. [17]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Role of the Maillard Reaction in Aging of Tissue Proteins
Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18714 · Cited by 366
Giardino, I., Edelstein, D., & Brownlee, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117296 · Cited by 364
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Research works printed but not linked: 2
- Kennedy L (1992) Glycation of immunoglobulins and serum proteins. In: Alberti KGMM, de Fronzo RA, Keen H, Zimmet P (eds) International Textbook of Dia- betes Mellitus, 2nd edn. John Wiley, Chichester pp 985±1007
- Neumann A, Schinzel R, Palm D, Riederer P, Munch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation end-product induced NF-kappaB acti- vation and cytokine expression. FEBS Letters 453: 283±287
Cited by
Items 101–200 of 1,005
Influence of lifestyle modification on arterial stiffness and wave reflections
TANAKA, H., & SAFAR, M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.07.008 · Cited by 215
Tea Polyphenol (−)-Epigallocatechin-3-Gallate: A New Trapping Agent of Reactive Dicarbonyl Species
Sang, S., Shao, X., Bai, N., Lo, C.-Y., Yang, C. S., & Ho, C.-T. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700190s · Cited by 212
Quan, C., Alcala, E., Petkovska, I., Matthews, D., Canova-Davis, E., Taticek, R., & Ma, S. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2007.09.027 · Cited by 206
Insulin Resistance and Type 2 Diabetes in High-Fat–Fed Mice Are Linked to High Glycotoxin Intake
Sandu, O., Song, K., Cai, W., Zheng, F., Uribarri, J., & Vlassara, H. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2314 · Cited by 213
“N-carboxymethyllysine, a chemically defined derivative of both glycoxidation and lipid peroxidation (27), however, is thought to contribute to oxidative stress and tissue damage and has proved a useful indicator of AGEs, correlating well with diabetes and aging (9,10,31) as well as with a range of diet-induced patholo…”
BackgroundIshiguro, H., Nakaigawa, N., Miyoshi, Y., Fujinami, K., Kubota, Y., & Uemura, H. (2005) · The Prostate · doi:10.1002/pros.20219 · Cited by 211
Dahms, N. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00317-3 · Cited by 203
Welsh, K. J., Kirkman, M. S., & Sacks, D. B. (2016) · Diabetes Care · doi:10.2337/dc15-2727 · Cited by 207
Association of type 2 diabetes with brain atrophy and cognitive impairment
Roberts, R. O., Knopman, D. S., Przybelski, S. A., Mielke, M. M., Kantarci, K., Preboske, G. M., Senjem, M. L., Pankratz, V. S., Geda, Y. E., Boeve, B. F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000269 · Cited by 211
Voulgari, Tentolouris, N., & Papadogiannis, D. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s11681 · Cited by 210
“ROSs play an important role in the development of DCM.(42,43) Matrix metalloproteinase 2 (MMP-2) is activated by ROS and contributes to the acute loss of myocardial contractile function by targeting and cleaving susceptible proteins including troponin I and α-actinin.”
The Mechanism of Hyperglycemia-Induced Renal Cell Injury in Diabetic Nephropathy Disease: An Update
Wu, T., Ding, L., Andoh, V., Zhang, J., & Chen, L. (2023) · Life · doi:10.3390/life13020539 · Cited by 179
“It is also considered to be one of the reasons hyperglycemia aggravates diabetes and related complications [41].”
BackgroundWu, J.-W., Hsieh, C.-L., Wang, H.-Y., & Chen, H.-Y. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2008.07.025 · Cited by 205
Advanced glycation end products and diabetic foot disease
Huijberts, M. S. P., Schaper, N. C., & Schalkwijk, C. G. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.861 · Cited by 201
Advanced Glycation in Health and Disease: Role of the Modern Environment
VLASSARA, H. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.051 · Cited by 207
Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
Matzinger, M., Fischhuber, K., & Heiss, E. H. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.015 · Cited by 204
Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification
Schalkwijk, C. G., Stehouwer, C. D. A., & van Hinsbergh, V. W. M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.488 · Cited by 206
Diabetes and retinal vascular dysfunction.
Shin, E. S., Sorenson, C. M., & Sheibani, N. (2015) · PubMed · doi:10.4103/2008-322x.143378 · Cited by 199
“[12] Excess glucose in the blood can have nonenzymatic chemical reactions with amino groups of proteins, lipids, and nucleic acids to produce AGEs.”
BackgroundType 2 diabetes and risk of cognitive impairment and dementia
Whitmer, R. A. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0058-7 · Cited by 197
Common pathophysiological mechanisms of chronic kidney disease: Therapeutic perspectives
López-Novoa, J. M., Martínez-Salgado, C., Rodríguez-Peña, A. B., & Hernández, F. J. L. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.006 · Cited by 189
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Ahmad, S., Khan, H., Siddiqui, Z., Khan, M. Y., Rehman, S., Shahab, U., Godovikova, T., Silnikov, V., & Moinuddin (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.001 · Cited by 192
Non-enzymatic Glycation of Bone Collagen Modifies Osteoclastic Activity and Differentiation
Valcourt, U., Merle, B., Gineyts, E., Viguet-Carrin, S., Delmas, P. D., & Garnero, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610536200 · Cited by 195
Moreira, P. I., Harris, P. L. R., Zhu, X., Santos, M. S., Oliveira, C. R., Smith, M. A., & Perry, G. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-12210 · Cited by 196
Polycystic ovary syndrome and environmental toxins
Rutkowska, A. Z., & Diamanti-Kandarakis, E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.08.031 · Cited by 192
Metabolic memory: mechanisms and diseases
Dong, H., Sun, Y., Nie, L., Cui, A., Zhao, P., Leung, W. K., & Wang, Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01755-x · Cited by 214
“186,187 The primary origin of AGEs is the endogenous process, whereby sugars react with amino groups of proteins, lipids, and nucleic acids through a series of non-enzymatic reactions.”
BackgroundA “Turn-On” Fluorescent Sensor for Methylglyoxal
Wang, T., Douglass, E. F., Fitzgerald, K. J., & Spiegel, D. A. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406077j · Cited by 195
Brocq, M. L., Leslie, S. J., Milliken, P., & Megson, I. L. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.2013 · Cited by 190
“The evidence in support of this argument comes from experiments in cultured endothelial cells, in which increased glucose concentration increases cytosolic ROS production, activation of NF-(cid:2) B, formation of AGEs, and activation of PKC, all of which were blocked with Mn-SOD, respiratory inhibitors, or uncoupling…”
InfluentialImpairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products
Biao, X., Chibber, R., Ruggiero, D., Kohner, E., Ritter, J., & Ferro, A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0490fje · Cited by 195
The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction
Sergi, D., Boulestin, H., Campbell, F. M., & Williams, L. M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900934 · Cited by 194
Advanced Glycation End Products: Building on the Concept of the “Common Soil” in Metabolic Disease
Ruiz, H. H., Ramasamy, R., & Schmidt, A. M. (2020) · Endocrinology · doi:10.1210/endocr/bqz006 · Cited by 184
Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., & Van Obberghen, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106534200 · Cited by 191
Diamanti-Kandarakis, E., Piperi, C., Patsouris, E., Korkolopoulou, P., Panidis, D., Pawelczyk, L., Papavassiliou, A. G., & Duleba, A. J. (2007) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0265-3 · Cited by 177
“Furthermore, the interaction of AGE-RAGE results in generation of intracellular oxidative stress and subsequent activation of the redoxsensitive transcription factors such as NF- B (Mohamed et al. 1999; Schmidt et al. 1999, 2000; Singh et al. 2001).”
BackgroundInfluentialPresence and Risk Factors for Glaucoma in Patients with Diabetes
Song, B. J., Aiello, L. P., & Pasquale, L. R. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0815-6 · Cited by 163
Mitochondrial dysfunction and complications associated with diabetes
Blake, R., & Trounce, I. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.007 · Cited by 190
“AGE also modify collagen-type proteins to decrease vessel elasticity, cell adhesion and matrix–matrix interaction [20,44].”
BackgroundKilhovd, B. K., Giardino, I., Torjesen, P. A., Birkeland, K. I., Berg, T. J., Thornalley, P. J., Brownlee, M., & Hanssen, K. F. (2003) · Metabolism · doi:10.1053/meta.2003.50035 · Cited by 187
Pathways of the Maillard reaction under physiological conditions
Henning, C., & Glomb, M. A. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9694-y · Cited by 189
Apple Polyphenols, Phloretin and Phloridzin: New Trapping Agents of Reactive Dicarbonyl Species
Shao, X., Bai, N., He, K., Ho, C.-T., Yang, C. S., & Sang, S. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800227v · Cited by 185
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
Flyvbjerg, A., Denner, L., Schrijvers, B. F., Tilton, R. G., Mogensen, T. H., Paludan, S. R., & Rasch, R. (2004) · Diabetes · doi:10.2337/diabetes.53.1.166 · Cited by 187
The metabolic syndrome and chronic kidney disease
Zhang, X., & Lerman, L. O. (2017) · Translational Research · doi:10.1016/j.trsl.2016.12.004 · Cited by 173
Sindhu, R. K., Koo, J., Roberts, C. K., & Vaziri, N. D. (2004) · Clinical and Experimental Hypertension · doi:10.1081/ceh-120027330 · Cited by 183
Fernando, D. H., Forbes, J. M., Angus, P. W., & Herath, C. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205037 · Cited by 184
“Advanced glycation end products are a biologically active group of compounds formed by non-enzymatic reaction between reducing-sugars with proteins, lipids and nucleic acids which were first discovered by Camille Maillard [13].”
BackgroundInfluentialChorvat, D., & Chorvatova, A. (2009) · Laser Physics Letters · doi:10.1002/lapl.200810132 · Cited by 182
Old Age and the Hepatic Sinusoid
Le Couteur, D. G., Warren, A., Cogger, V. C., Smedsrød, B., Sørensen, K. K., De Cabo, R., Fraser, R., & Mccuskey, R. S. (2008) · The Anatomical Record · doi:10.1002/ar.20661 · Cited by 177
“Of note, advanced AGEs are linked with many age-related diseases such as diabetes mellitus, atherosclerosis, and dementia (Singh et al., 2001).”
BackgroundTanaka, K.-I., Yamaguchi, T., Kanazawa, I., & Sugimoto, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.091 · Cited by 178
McNulty, P. H., King, N., Scott, S., Hartman, G., McCann, J., Kozak, M., Chambers, C. E., Demers, L. M., & Sinoway, L. I. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00625.2004 · Cited by 180
Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease Incidence
van Hecke, M. V., Dekker, J. M., Stehouwer, C. D. A., Polak, B. C. P., Fuller, J. H., Sjolie, A. K., Kofinis, A., Rottiers, R., Porta, M., & Chaturvedi, N. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1383 · Cited by 176
Schiekofer, S., Andrassy, M., Chen, J., Rudofsky, G., Schneider, J., Wendt, T., Stefan, N., Humpert, P., Fritsche, A., Stumvoll, M., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.621 · Cited by 180
“However, the inhibition of NF- B activation and the inhibition of intracellular AGE formation by aminoguanidin, an inhibitor of electron transport chain complex II, an uncoupler of oxidative phosphorylation, uncoupling protein-1, or manganese superoxide dismutase (35,52,53) allows us to speculate that intracellular CM…”
BackgroundChen, C., Zhang, J., Li, L., Guo, M., He, Y., Dong, Y., Meng, H., & Yi, F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.837222 · Cited by 203
Reduced Oxidant Stress and Extended Lifespan in Mice Exposed to a Low Glycotoxin Diet
Cai, W., He, J. C., Zhu, L., Chen, X., Wallenstein, S., Striker, G. E., & Vlassara, H. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061281 · Cited by 175
Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
Funk, S. D., Yurdagul, A., & Orr, A. W. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/569654 · Cited by 176
“med Amadori products, take one of two pathways: an oxidative or nonoxidative pathway forming irreversible AGE modifications [142, 143].”
BackgroundGirard, A. L., & Awika, J. M. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12572 · Cited by 181
Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A. G., & Panidis, D. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03247.x · Cited by 174
Lu, J., Wu, D.-M., Zheng, Y.-L., Hu, B., Zhang, Z.-F., Ye, Q., Liu, C.-M., Shan, Q., & Wang, Y.-J. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhq002 · Cited by 174
“Latest reports indicate that AGEs binding to its receptor (RAGE) leads to NF-jB activation which allows its translocation to the nucleus, where it regulates the expression of a large number of genes, including TNF-a, IL-1b, and RAGE (Singh et al. 2001; Evans et al. 2002).”
BackgroundAn overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and inhibition
Uceda, A. B., Mariño, L., Casasnovas, R., & Adrover, M. (2024) · Biophysical Reviews · doi:10.1007/s12551-024-01188-4 · Cited by 188
“For instance, the direct involvement of glycation in the pathogenesis of diabetic complications, such as neuropathy, cardiomyopathy, nephropathy, or retinopathy, is well established (e.g., Singh et al. 2001).”
BackgroundSun, Y., Hayakawa, S., & Izumori, K. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030428s · Cited by 168
Features and regulation of non-enzymatic post-translational modifications
Harmel, R., & Fiedler, D. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2575 · Cited by 166
Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells
Talmor, Y., Golan, E., Benchetrit, S., Bernheim, J., Klein, O., Green, J., & Rashid, G. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00051.2008 · Cited by 169
Synthesis of bis-Schiff bases of isatins and their antiglycation activity
Khan, K. M., Khan, M., Ali, M., Taha, M., Rasheed, S., Perveen, S., & Choudhary, M. I. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.09.028 · Cited by 169
The role of phosphatidylserine recognition receptors in multiple biological functions
Naeini, M. B., Bianconi, V., Pirro, M., & Sahebkar, A. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00214-z · Cited by 182
“RAGE is a transmembrane receptor of the immunoglobulin superfamily which binds to advanced glycation end products (AGEs) [181, 182].”
BackgroundAdvanced glycation end products and the progressive course of renal disease
Heidland, A., Sebekova, K., & Schinzel, R. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27414 · Cited by 168
Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases
Kandarakis, S. A., Piperi, C., Topouzis, F., & Papavassiliou, A. G. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.05.002 · Cited by 158
“Intraocular VEGF levels are increased in diabetic patients where there is a significant correlation between AGEs and the development of diabetic vasculopathy (Aiello et al., 1994; Fonseca et al., 1996; Singh et al., 2001a, 2001b).”
BackgroundKilhovd, B. K., Juutilainen, A., Lehto, S., Rönnemaa, T., Torjesen, P. A., Hanssen, K. F., & Laakso, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0687-z · Cited by 165
Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity
Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835aea13 · Cited by 166
“Therefore, accelerated AGEs/ALEs formation is seen in diabetes, but also in age-related diseases, such as atherosclerosis and neurodegenerative disorders including Alzheimer’s disease [3,7].”
BackgroundEssential Structural Requirements and Additive Effects for Flavonoids to Scavenge Methylglyoxal
Shao, X., Chen, H., Zhu, Y., Sedighi, R., Ho, C.-T., & Sang, S. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500204s · Cited by 162
Flavonol glycosides from the leaves of Eucommia ulmoides O. with glycation inhibitory activity
Kim, H. Y., Moon, B. H., Lee, H. J., & Choi, D. H. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.03.047 · Cited by 161
Sleep Apnea and Glucose Metabolism
Lindberg, E., Theorell-Haglöw, J., Svensson, M., Gislason, T., Berne, C., & Janson, C. (2012) · Chest · doi:10.1378/chest.11-1844 · Cited by 162
Alikhani, M., MacLellan, C. M., Raptis, M., Vora, S., Trackman, P. C., & Graves, D. T. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00356.2006 · Cited by 162
“The N -(carboxymethyl)lysine (CML) structure is a prevalent AGE and is generated principally by oxidative cleavage of Amadori intermediates (40).”
BackgroundChen, L., Hu, F. B., Yeung, E., Willett, W., & Zhang, C. (2009) · Diabetes Care · doi:10.2337/dc09-0866 · Cited by 150
“Because caramel coloring in cola-type beverages has been positively associated with insulin resistance and inflammation in animals (16), we further examined the associations between two types of SSBs (cola versus noncola) and GDM risk.”
BackgroundLi, L., Sawamura, T., & Renier, G. (2004) · Circulation Research · doi:10.1161/01.res.0000124920.09738.26 · Cited by 161
“To measure amounts of Dil-oxLDL accumulated in cells, DiI was extracted by isopropanol and the fluorescence was determined at 520/564 nm. Quantification of cytosolic AGE in MDM The total AGE content present in the cytosolic extracts of glucose-treated MDM was determined by competitive ELISA.4 Briefly, BSA was glycated…”
MethodInfluentialBone disease in diabetes: another manifestation of microvascular disease?
Shanbhogue, V. V., Hansen, S., Frost, M., Brixen, K., & Hermann, A. P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30134-1 · Cited by 158
Nakajou, K., Watanabe, H., Kragh‐Hansen, U., Maruyama, T., & Otagiri, M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2003.08.001 · Cited by 158
Wang, Z., Jiang, Y., Liu, N., Ren, L., Zhu, Y., An, Y., & Chen, D. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.019 · Cited by 171
Oxidative Stress in Preterm Newborns
Lembo, C., Buonocore, G., & Perrone, S. (2021) · Antioxidants · doi:10.3390/antiox10111672 · Cited by 168
“8-Hydroxy-2′-deoxyguanosine (8-OHdG) is an oxidized nucleoside released upon repair of damaged DNA, used as a biomarker of OS-related DNA damage.”
BackgroundInfluentialHAGEN, T. M., MOREAU, R., SUH, J. H., & VISIOLI, F. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02119.x · Cited by 155
Cloos, P. A., & Christgau, S. (2004) · Biogerontology · doi:10.1023/b:bgen.0000031152.31352.8b · Cited by 169
“AGE formation may be induced by inflammatory processes (Singh et al. 2001; Ulrich and Cerami 2001), and some AGE-modified proteins have been shown to be immunogenic (Ikeda et al. 1996).”
BackgroundFessel, G., Li, Y., Diederich, V., Guizar‐Sicairos, M., Schneider, P., Sell, D. R., Monnier, V. M., & Snedeker, J. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110948 · Cited by 158
Babizhayev, M. A., Strokov, I. A., Nosikov, V. V., Savel'yeva, E. L., Sitnikov, V. F., Yegorov, Y. E., & Lankin, V. Z. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0365-y · Cited by 168
“A number of common foods contain AGEs that can increase the AGE-induced stress in diabetic patients and promote nephropathy [35].”
BackgroundTan, K. C. B., Shiu, S. W. M., Chow, W. S., Leng, L., Bucala, R., & Betteridge, D. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0394-1 · Cited by 158
“of AGEs, the binding of which to their cellular receptors plays an important role in the development of diabetic vascular complications [1].”
BackgroundKalantarinia, K., Awad, A. S., & Siragy, H. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00237.x · Cited by 156
Karsdal, M. A., Henriksen, K., Leeming, D. J., WOODWORTH, T. G., Vassiliadis, E., & Bay‐Jensen, A. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.03.015 · Cited by 162
Aldini, G., Vistoli, G., Stefek, M., Chondrogianni, N., Grune, T., Sereikaite, J., Sadowska-Bartosz, I., & Bartosz, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.792926 · Cited by 150
“Advanced glycation end products (AGEs) are the final products of the non-enzymatic reaction of reducing sugars and reactive aldehydes with amino-groups on macromolecules such as proteins, lipids or nucleic acids [320, 321].”
BackgroundAdvanced glycation end product level, diabetes, and accelerated cognitive aging
Yaffe, K., Lindquist, K., Schwartz, A. V., Vitartas, C., Vittinghoff, E., Satterfield, S., Simonsick, E. M., Launer, L., Rosano, C., Cauley, J. A., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182315a56 · Cited by 150
Glycotoxines, Carbonyl Stress and Relevance to Diabetes and Its Complications
Turk, Z. (2010) · Physiological Research · doi:10.33549/physiolres.931585 · Cited by 162
Berrone, E., Beltramo, E., Solimine, C., Ape, A. U., & Porta, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600418200 · Cited by 148
Periodontal disease: the influence of metabolic syndrome
Marchetti, E., Monaco, A., Procaccini, L., Mummolo, S., Gatto, R., Tetè, S., Baldini, A., Tecco, S., & Marzo, G. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-88 · Cited by 184
Noureddin, M., Zelber‐Sagi, S., Wilkens, L. R., Porcel, J., Boushey, C. J., Le Marchand, L., Rosen, H. R., & Setiawan, V. W. (2020) · Hepatology · doi:10.1002/hep.30967 · Cited by 148
“HAAs have been shown to increase oxidative stress, which is a key step in the pathophysiology of NASH and ultimately cirrhosis.(26-28) Collectively, these findings highlight the possible harmful effects of red meat and their association with NAFLD.”
BackgroundFranke, S., Siggelkow, H., Wolf, G., & Hein, G. E. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701602523 · Cited by 155
“They are involved in altering physicochemical and mechanical properties of tissue components that can reduce tissue quality (Vlassara et al., 1994; Ulrich & Cerami, 2001; Singh et al., 2001; Bohlender et al., 2005).”
BackgroundTraverso, N., Menini, S., Maineri, E. P., Patriarca, S., Odetti, P. R., Cottalasso, D., Marinari, U. M., & Pronzato, M. A. (2004) · The Journals of Gerontology Series A · doi:10.1093/gerona/59.9.b890 · Cited by 148
Elimination of damaged proteins during differentiation of embryonic stem cells
Hernebring, M., Brolén, G., Aguilaniu, H., Semb, H., & Nyström, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510944103 · Cited by 146
Microglial priming of antigen presentation and adaptive stimulation in Alzheimer’s disease
Das, R., & Chinnathambi, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03132-2 · Cited by 147
Oxidative Stress in Aging-Matters of the Heart and Mind
Venkataraman, K., Khurana, S., & Tai, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917897 · Cited by 142
“pathologies, including formation of amyloid plaques in the development of Alzheimer’s disease [4].”
BackgroundAdvanced glycation and endothelial functions: A link towards vascular complications in diabetes
Rojas, A., & Morales, M. A. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.09.011 · Cited by 165
Twigg, S. M., Cao, Z., McLennan, S. V., Burns, W. C., Brammar, G., Forbes, J. M., & Cooper, M. E. (2002) · Endocrinology · doi:10.1210/en.2002-220619 · Cited by 143
“These endproducts of nonenzymatic glycation of protein and lipid, which are increased in diabetic tissues, can induce the cellular formation of cytokines and growth factors, which may themselves then contribute to diabetic renal disease (2, 3).”
BackgroundO’Connor, T. P., Lee, A., Jarvis, J. U. M., & Buffenstein, R. (2002) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(02)00198-8 · Cited by 154
Age-Related Influence on Thiol, Disulfide, and Protein-Mixed Disulfide Levels in Human Plasma
Giustarini, D., Dalle-Donne, I., Lorenzini, S., Milzani, A., & Rossi, R. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1030 · Cited by 143
“Aging tissue shows a progressive accumulation of oxidatively modified biomolecules such as carbonylated proteins (6), advanced glycation end products ( 7 ), lipid peroxidation products (8), and lipofuscin (9).”
BackgroundRole of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy
Jack, M. M., & Wright, D. E. (2012) · Translational research · doi:10.1016/j.trsl.2011.12.004 · Cited by 155
Approaches to prevention of cardiovascular complications and events in diabetes mellitus
Coccheri, S. (2007) · Drugs · doi:10.2165/00003495-200767070-00005 · Cited by 139
The vascular endothelium: A regulator of arterial tone and interface for the immune system
Khaddaj‐Mallat, R., John, C. M., Kendrick, D. J., & Braun, A. P. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1394267 · Cited by 148
Chen, Y., Meng, Z., Li, Y., Liu, S., Hu, P. L., & Luo, E. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00905-9 · Cited by 153
Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart
Lim, H. S., MacFadyen, R. J., & Lip, G. Y. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.16.1737 · Cited by 138
“FUTURE PERSPECTIVES There is a complex relationship between generalized atherosclerosis and the separate process of pancreatic failure, whether absolute, as in type 1 DM, or relative, as in type 2 DM. Obesity and its epidemic effects on westernized cultures and dietary habits has a key role to play in arterial pressur…”
BackgroundInfluentialXu, Y., Liu, G., Yu, Z., Song, X., Li, X., Yang, Y., Wang, L., Liu, L., & Dai, J. (2015) · Food Chemistry · doi:10.1016/j.foodchem.2015.12.078 · Cited by 138
Tannins and vascular complications of Diabetes: An update
Laddha, A. P., & Kulkarni, Y. A. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.026 · Cited by 148
Metadata
- Authors
- Singh, R., Barden, A., Mori, T., & Beilin, L.
- Affiliations
- The University of Western Australia (AU)
- Venue
- Diabetologia
- Published
- 2001-02-05
- Volume
- 44
- Issue
- 2
- Pages
- 129-146
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1966234811
- Cited by
- 2,597
- References
- 45
- Citations by year
- 2026: 67 · 2025: 85 · 2024: 124 · 2023: 117 · 2022: 152 · 2021: 161 · 2020: 138 · 2019: 142 · 2018: 118 · 2017: 118 · 2016: 130 · 2015: 139 · 2014: 132 · 2013: 114 · 2012: 132
- FWCI
- 36.26
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-30)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- advanced glycation end products, diabetes complications, diabetic microvascular complications, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, diabetic vascular disease, carbonyl stress, aminoguanidine
- MeSH terms
- Receptor for Advanced Glycation End Products, Aging, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Neuropathies, Diabetic Retinopathy, Food, Humans, Plants, Toxic, Receptors, Immunologic, Nicotiana, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.